CAVEATS IN INTERPRETING AND COMPARING LONG-TERM EFFICACY IN BIOLOGIC STUDIES FOR MODERATE-TO-SEVERE PLAQUE PSORIASIS

被引：0
|
作者：
Langley, Richard G. [1 ]
Egeberg, Alexander [2 ]
Gooderham, Melinda [3 ,4 ]
Bissonnette, Robert [5 ]
Ringuet, Julien [6 ]
Kalia, Sunil [7 ]
Park-Wyllie, Laura [8 ]
Abbarin, Nastaran [8 ]
Tran, Diana [9 ]
Zara, Anthony [9 ]
Yang, Ya-Wen [10 ]
Strober, Bruce [11 ,12 ]
机构：
[1] Dalhousie Univ, Halifax, NS, Canada
[2] Bispebjerg Hosp, Copenhagen, Denmark
[3] SKiN Ctr Dermatol & Prob Med Res, Kingston, ON, Canada
[4] Queens Univ, Kingston, ON, Canada
[5] Innovaderm Res Inc, Montreal, PQ, Canada
[6] Ctr Rech Dermatol Quebec Metropolitain CRDQ, Quebec City, PQ, Canada
[7] Univ British Columbia, Vancouver, BC, Canada
[8] Janssen Inc, Toronto, ON, Canada
[9] EVERSA NA, Burlington, ON, Canada
[10] Johnson & Johnson, Janssen Pharmaceut Co, Titusville, NJ USA
[11] Cent Connecticut Dermatol Res, Cromwell, CT USA
[12] Yale Univ, New Haven, CT USA
来源：
ACTA DERMATO-VENEREOLOGICA | 2024年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P-031
引用
收藏
页数：102
相关论文
共 50 条
  • [41] Long-Term Treatment Patterns of Biologics and Apremilast Among Patients with Moderate-to-Severe Plaque Psoriasis by Psoriatic Arthritis Status
    Feldman, Steven
    Zhang, Jingchuan
    Martinez, Diane
    Lopez-Gonzalez, Lorena
    Marchlewicz, Elizabeth Holt
    Shrady, George
    Mendelsohn, Alan
    Zhao, Yang
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [42] Long-term treatment with etanercept monotherapy in a hemodialyzed patient with moderate-to-severe plaque-type psoriasis and psoriatic arthritis
    Babino, Graziella
    Esposito, Maria
    Bianchi, Luca
    Giunta, Alessandro
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2018, 153 (06): : 882 - 884
  • [43] Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasis
    Leonardi, C.
    Papp, K.
    Strober, B.
    Thaci, D.
    Warren, R. B.
    Tyring, S.
    Arikan, D.
    Karunaratne, M.
    Valdecantos, W. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 76 - 85
  • [44] Efficacy of risankizumab in moderate-to-severe plaque psoriasis by baseline characteristics and prior therapies
    Strober, B.
    Valdecantos, W.
    Zhan, T.
    Lambert, J.
    Menter, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 42 - 43
  • [45] Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis
    Elewski, Boni
    Menter, Alan
    Crowley, Jeffrey
    Tyring, Stephen
    Zhao, Yang
    Lowry, Simon
    Rozzo, Stephen
    Mendelsohn, Alan M.
    Parno, Jeffrey
    Gordon, Kenneth
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (08) : 763 - 768
  • [46] Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
    Egeberg, A.
    Ottosen, M. B.
    Gniadecki, R.
    Broesby-Olsen, S.
    Dam, T. N.
    Bryld, L. E.
    Rasmussen, M. K.
    Skov, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 509 - 519
  • [47] Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and comorbid diabetes mellitus
    Egeberg, A.
    Schaekel, K.
    Puig, L.
    Saure, D.
    Yali Wang, I.
    Pavo, I.
    Mahar, P.
    Schuster, C.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E31 - E31
  • [48] Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
    Egeberg, A.
    Ottosen, M. B.
    Gniadecki, R.
    Broesby-Olsen, S.
    Dam, T.
    Bryld, L. E.
    Rasmussen, M. K.
    Skov, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E284 - E285
  • [49] Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment
    Lucka, T. C.
    Pathirana, D.
    Sammain, A.
    Bachmann, F.
    Rosumeck, S.
    Erdmann, R.
    Schmitt, J.
    Orawa, H.
    Rzany, B.
    Nast, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (11) : 1331 - 1344
  • [50] Long-term efficacy of brodalumab for the treatment of moderate-to-severe psoriasis in two pivotal phase 3 clinical trials
    Lebwohl, Mark
    Papp, Kim A.
    Tyring, Stephen
    Krueger, James
    Rastogi, Shipra
    Pillai, Radhakrishnan
    Israel, Robert J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB180 - AB180
12345